Table 2 Effect of raloxifene on mortality after adjusting for variables
Regression coefficient | SE | P value | HR | |
|---|---|---|---|---|
Age (years) | .029 | .018 | .105 | 1.029 |
Body mass index (kg/m2) | -.032 | .030 | .289 | .968 |
Diabetes | -.567 | .294 | .054 | .567 |
Hypertension | -.159 | .273 | .560 | .853 |
Neurological disease | .235 | 1.057 | .824 | 1.265 |
Liver disease | -.554 | .497 | .265 | .574 |
Cardiovascular disease | .676 | .730 | .355 | 1.966 |
Pulmonary disease | .214 | .604 | .723 | 1.239 |
Raloxifene use | 1.347 | .364 | .000 | 3.845 |